Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEPT3 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
mRNA | GPRIN1 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
mRNA | SH3GL2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | TIA1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | ZNF22 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-08 |
mRNA | JADE3 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | ZNF713 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | GRM2 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
mRNA | PMAIP1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |